Business Wire Feed
CORRECTING and REPLACING ATL Medical Integrates OMNIVISION’s OVMed® OH0131 Image Signal Processor into Its PREVOYANCE® Medical Imaging System
The OVMed® ISP OH0131 features advanced image algorithms to optimize brightness, contrast, saturation, hue and sharpness, along with advanced noise reduction capabilitiesSANTA CLARA, Calif. & SPRINGVILLE, Utah--(BUSINESS WIRE)--#InfiniteIngenuity--In the second paragraph, first sentence following the more...
MedeAnalytics Showcases How Health Plans Turn AI-Driven Insights into Measurable Performance Improvement
RICHARDSON, Texas--(BUSINESS WIRE)--#MLR--MedeAnalytics, the healthcare performance improvement company, today announced its participation in a series of leading payer-focused industry events, including a Becker’s Payer Issues webinar, the 2026 Becker’s Payer Issues Spring Roundtable, and 2026 more...
Spacelabs Healthcare Announces Agreement to Provide its Rothman Index® to Hospitals and Health Systems Through DEPTH Health
SNOQUALMIE, Wash.--(BUSINESS WIRE)--Spacelabs Healthcare today announced that it has signed an agreement with DEPTH Health, Inc., a leader in patient traffic flow optimization technology, that will allow DEPTH Health to provide hospitals and health systems more...
After an Autism Diagnosis: Expert Guidance from Acorn Health
CORAL GABLES, Fla.--(BUSINESS WIRE)--#ABATherapy--April is Autism Acceptance Month, a time focused on awareness, acceptance and advocacy, beginning with World Autism Awareness Day on April 2. For many families, the month brings education and reflection. For more...
Agenus Announces Data from Phase II Study of BOT+BAL in Combination with agent-797 in PD-1 Refractory Gastroesophageal Cancer to be Presented at AACR 2026
Study highlights novel multi-mechanistic immunotherapy combination in checkpoint-refractory disease Data expected to inform immune modulation, treatment sequencing, and durability of response across hard-to-treat tumors LEXINGTON, Mass.--(BUSINESS WIRE)--$AGEN #AACR2026--Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology more...
Innate Pharma to Participate in the Kempen Life Sciences Conference
MARSEILLE, France--(BUSINESS WIRE)--#Biotech--Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”), a clinical-stage biotechnology company developing immunotherapies for cancer patients, today announced that members of its executive team will participate more...
Alcon Publishes Agenda for 2026 Annual General Meeting
Alcon welcomes its shareholders to its fourth in-person AGM Alcon Board of Directors proposes to elect R. Scott Herren as a new independent Board member Proposed dividend of CHF 0.28 cash per share GENEVA--(BUSINESS WIRE)--Alcon more...
Nu Skin Launches Prysm iO™: A Revolutionary AI-Powered Platform for Personalized Nutritional Wellness
Breakthrough intelligent platform measures skin carotenoid levels for antioxidant insights in just 15 seconds, empowering consumers to take control of their nutritional wellnessPROVO, Utah--(BUSINESS WIRE)--Nu Skin Enterprises Inc. (NYSE: NUS), the world's #1 company for more...
Vedanta Biosciences Announces the Phase 3 RESTORATiVE303 Study of VE303 for the Prevention of Recurrent C. difficile Infection Will Continue as Planned Following Protocol-Specified Interim Analysis
Independent Data Monitoring Committee Recommendation was Based on Review of Safety and Efficacy; Enrollment Expected to Complete in 2H 2026CAMBRIDGE, Mass.--(BUSINESS WIRE)--Vedanta Biosciences, a late clinical-stage biopharmaceutical company developing microbiome-based oral therapies for gastrointestinal diseases, more...
CONMED Corporation to Announce First Quarter 2026 Financial Results on April 29, 2026
LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced that it will report financial results for the first quarter 2026 after the market close on Wednesday, April 29, 2026. The Company’s management will host a conference more...
Pulse Biosciences to Present at the 25th Annual Needham Virtual Healthcare Conference
HAYWARD, Calif.--(BUSINESS WIRE)--Pulse Biosciences, Inc. (Nasdaq: PLSE), pioneer of the novel nPulse™ platform using proprietary Nanosecond Pulsed Field Ablation (nsPFA™), today announced plans to present at the upcoming 25th Annual Needham Virtual Healthcare Conference. Pulse more...
Hinge Health to announce first quarter 2026 financial results on May 5, 2026
SAN FRANCISCO--(BUSINESS WIRE)--Hinge Health, Inc. (NYSE: HNGE) announced today that it will report its financial results for the quarter ended March 31, 2026, after the U.S. financial markets close on Tuesday, May 5, 2026. Hinge more...
Tandem Diabetes Care to Announce First Quarter 2026 Financial Results on May 7, 2026
SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, plans to release its first quarter 2026 results after the financial markets close on Thursday, May 7, 2026. The more...
SV Health Investors Acquires EpiVax
BOSTON--(BUSINESS WIRE)--SV Health Investors (“SVHI”), a healthcare and life sciences focused private investment firm, announced today the acquisition of EpiVax, Inc. Headquartered in Providence, RI, EpiVax is a leading bioanalytical CRO specializing in immunogenicity risk more...
Fortive Schedules First Quarter 2026 Earnings Conference Call
EVERETT, Wash.--(BUSINESS WIRE)--Fortive Corporation (“Fortive”) (NYSE: FTV) today announced that it will webcast its earnings conference call for the first quarter 2026 on Thursday, April 30, 2026, beginning at 12:00 p.m. ET and lasting approximately more...
WellStack Partners with Healthcare Systems of America to Establish a Unified Data Foundation and Enable Enterprise Analytics
MADISON, Wis.--(BUSINESS WIRE)--WellStack, a healthcare data platform purpose-built to enable analytics, AI readiness, and confident decision-making, today announced a multi-year strategic partnership with Healthcare Systems of America (HSA), a leading hospital services organization supporting health more...
Strong Signal for Investors: VR LIFE and H2 Global Group Validate the Value of European MedTech Innovation
PRAGUE--(BUSINESS WIRE)--H2 Global Group is strengthening its position as a European technology group connecting capital with clinically validated healthcare innovations. A prime example is VR LIFE and its flagship MDR-certified medical device, VR Vitalis Pro. more...
Feinstein Institutes 2026 Ross Prize awarded to Drs. Michel Sadelain and Carl H. June
The 13th Annual Ross Prize Symposium will be held June 11 in New York CityMANHASSET, N.Y.--(BUSINESS WIRE)--The Feinstein Institutes for Medical Research has selected Carl H. June, MD, from the University of Pennsylvania Perelman School more...
OpenEvidence and Tandem Partner to Streamline Evidence-Based Prescribing and Prior Authorizations
OpenEvidence powers the clinical decision backed by evidence and Tandem automates every step from prescription to patientMIAMI & NEW YORK--(BUSINESS WIRE)--OpenEvidence, the leader in AI-powered medical search and clinical decision support, and Tandem, the leader more...
Unprecedented Early-Stage Cancer Detection Presented at AACR 2026
Dxcover Highlights Liquid Biopsy Platform Performance in Multiple SettingsGLASGOW, Scotland--(BUSINESS WIRE)--Dxcover, a global leader in AI-enabled technologies, today announced the presentation of multiple studies at the American Association for Cancer Research (AACR) Annual Meeting taking more...
CTIS, Inc. Launches Trial SafetyXchange to Help Pharma Companies Meet Critical FDA E2B(R3) Compliance Deadline
Affordable, cloud-based SaaS solution automates E2B (R2) to E2B (R3) conversion for small and mid-size pharma organizationsROCKVILLE, Md.--(BUSINESS WIRE)--CTIS, Inc., with more than 30 years of experience in Health IT and clinical research informatics expertise more...
PharmaEssentia Signs Investment Agreement for New Manufacturing Facility in Puerto Rico
A pivotal step in PharmaEssentia's dual-site U.S.-Taiwan manufacturing strategy, with 2027 operations in sightBURLINGTON, Mass.--(BUSINESS WIRE)--PharmaEssentia Corporation (TWSE: 6446), a global biopharmaceutical company headquartered in Taiwan, announced that on Thursday, March 26, it signed an more...
EarliPoint™ Health and Netsmart Partner to Expand Reach of Groundbreaking Autism Assessment Technology
OVERLAND PARK, Kan.--(BUSINESS WIRE)--#AutismDiagnosis--Netsmart, an industry-leading provider of healthcare IT and services with purpose-built electronic health record (EHR) solutions for autism and intellectual and developmental disabilities (IDD), announces a new partnership with EarliPoint Health, developer more...
Welldoc Certified as a Great Place to Work® for Fifth Consecutive Year
95% percent of employees name Welldoc a great place to work, outperforming the U.S. average by 38 points.COLUMBIA, Md.--(BUSINESS WIRE)--Welldoc®, an AI-powered health tech leader, today announced that it has been Certified™ by Great Place more...
CUPE members preparing for province-wide action after negotiations stall at the Extendicare Central Table
Markham, ON--(BUSINESS WIRE)--Members of CUPE’s central negotiation table are preparing for a summer of action after negotiations with Extendicare’s management team stalled this week. The parties met at CUPE’s Ontario Regional office to negotiate a more...